Ranran Kong

635 citations
37 papers · 445 indexed · h-index 14
Topics
RNA modifications and cancer (9 papers)Circular RNAs in diseases (6 papers)MicroRNA in disease regulation (5 papers)
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Ranran Kong

32 papers receiving 442 citations

Peers

Ranran Kong
Comparison fields: 5 of 64
  • Molecular Biology 331
  • Cancer Research 189
  • Oncology 107
  • Pulmonary and Respiratory Medicine 67
  • Immunology 51
Replace Junli Deng with:
Junli Deng China
Namrata Bhatnagar United States
Wolong Zhou China
Bi‐Jun Huang China
Aman Wang China
Haoyi Jin China
Meisongzhu Yang China
Barbara Antoniani Italy
Shi-Rong Zhang China
Ranran Kong relative to Junli Deng China Junli Deng's profile →
Citations per field
00.5×1.5×
Junli Deng · 1×
Citations per year

Countries citing papers authored by Ranran Kong

Since Specialization
Citations

This map shows the geographic impact of Ranran Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranran Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranran Kong more than expected).

Fields of papers citing papers by Ranran Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ranran Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranran Kong. The network helps show where Ranran Kong may publish in the future.

Co-authorship network of co-authors of Ranran Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Ranran Kong. A scholar is included among the top collaborators of Ranran Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ranran Kong. Ranran Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 0
5 3
6 2
7 8
8 18
9 12
10 2
11 47
12 26
13 22
14 27
15 8
16 13
17 9
18 16
19 15
20
Immunohistochemical Expression and Significance of Matrix Metalloproteinase-7,Matrix Metalloproteinase-9,Tissue Inhibitor of Metalloproteinase-3 in Osteoarthritis Patients' Synovium of Knee Joint
1

About Ranran Kong

Ranran Kong is a scholar working on Cancer Research, Toxicology and Nephrology, having authored 37 papers that have together received 445 indexed citations. Recurring topics across this work include RNA modifications and cancer (9 papers), Circular RNAs in diseases (6 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Cancer Research (189 citations), Molecular Biology (331 citations) and Oncology (107 citations). Ranran Kong has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Shaomin Li, Yuefeng Ma, Zhe Qiao, Jie Feng, Jiantao Jiang, Xinwu Zhang, Bin Zhou, Jin Zhang, Xiaoping Yang and Seungyeul Yoo. Their work appears in journals such as Nature Communications, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026